Latest news with #AmazonAWS
News18
17 hours ago
- Business
- News18
Zerodha Unveils WhatsApp-Based Kite Backup For Emergency Trading: How To Use It
Zerodha launched Kite Backup, a WhatsApp-based system for traders to manage positions if Kite's main platforms fail. Zerodha WhatsApp-Based Kite Backup: India's largest stockbroker Zerodha has launched Kite Backup, a WhatsApp-based emergency system that allows traders to square off open positions and cancel pending orders if its primary platforms – Kite web and mobile – ever go down during market hours. Trading platforms are highly complex, with multiple systems linked to exchanges, data centres, and cloud providers. Despite several layers of redundancy, a rare technical glitch at any point can disrupt trading. To provide an additional safety net, Zerodha has created this fully independent backup channel. Unlike the regular Kite systems that run on Amazon AWS and are protected by Cloudflare, the new WhatsApp-based setup is hosted on Microsoft Azure and connects directly to multiple order management systems (OMS) in physical data centres. It does not rely on Kite's primary infrastructure, ensuring that even if AWS or Cloudflare face outages, users can still exit positions. Limitations The Kite Backup system over WhatsApp is designed to be a last resort in case all primary trading platforms become unavailable. It is NOT designed to be a trading or investment platform. The WhatsApp Flow offers only a rudimentary interface that permits very few interactions. You can view holdings, margins, open orders and positions. Open orders and positions can be squared off. New orders or any other advanced features are not available. The backup system offers redundancy over Kite's trading systems and infrastructure, such as Amazon AWS and Cloudflare, which Kite depends on. However, it does not offer redundancy over the core OMS (Order Management Systems) located in physical data centres. OMS systems have different redundancy measures. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Yahoo
a day ago
- Business
- Yahoo
Biotricity Inc (BTCY) Q1 2026 Earnings Call Highlights: A Milestone Quarter with Positive ...
Release Date: August 14, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Biotricity Inc (BTCY) achieved a significant milestone by reporting positive EBITDA for the first time in its history, indicating a path towards profitability. The company reported a 21% increase in revenue for the first quarter of fiscal 2026, reaching $3.9 million, driven by strong market adoption of its technology. Biotricity Inc (BTCY) has expanded its cardiac AI cloud platform through strategic partnerships with Amazon AWS and Google's Tensorflow, enhancing diagnostic accuracy and patient outcomes. The company has secured regulatory approvals in multiple international markets, including Canada, Saudi Arabia, and Argentina, aligning with its strategy for global expansion. Gross profit for the quarter increased by 31.9% to $3.1 million, with a gross profit margin improvement to 80.5%, reflecting operational efficiencies and a strong recurring revenue base. Negative Points Despite improvements, Biotricity Inc (BTCY) reported a net loss of $754,000 for the first quarter, although this was a significant improvement from the prior year's loss. The company faces challenges with rising variable interest rates, which could impact future financial performance. Biotricity Inc (BTCY) is still in the process of pursuing FDA clearance for its AI clinical model, which could delay the full commercialization of its new technologies. Operating expenses, although reduced, remain a concern as the company continues to invest in R&D and sales force transformation. The company's expansion into new verticals and international markets may require significant resources and could face regulatory and competitive challenges. Q & A Highlights Warning! GuruFocus has detected 6 Warning Signs with BTCY. Q: Can you provide more details on the strategic partnerships mentioned in the call? A: Dr. Walkus Al Sadiq, CEO, highlighted that Biotricity has formed strategic partnerships with industry giants like Amazon AWS and Google's Tensorflow to expand their cardiac AI cloud platform. These partnerships are crucial for enhancing diagnostic accuracy and improving patient outcomes. Additionally, alliances with three major group purchasing organizations (GPOs) in the US provide access to approximately 90% of hospitals, significantly expanding market access. Q: What are the financial highlights for the first quarter of fiscal 2026? A: Johnny Abo, CFO, reported a 21% increase in revenue to $3.9 million compared to the previous year. Gross profit rose by 31.9% to $3.1 million, with a gross profit margin improvement to 80.5%. Operating expenses decreased by 18.5%, and the company achieved a positive EBITDA of $333,000, marking the first quarter of positive EBITDA in Biotricity's history. Q: How is Biotricity addressing the market for atrial fibrillation monitoring? A: The CFO emphasized that atrial fibrillation, a major contributor to strokes, remains a significant focus. Biotricity's technology has monitored over 2 trillion heartbeats, providing early intervention opportunities and improving patient outcomes. This focus not only enhances patient care but also offers potential healthcare cost savings. Q: What are the future growth prospects for Biotricity? A: Dr. Walkus Al Sadiq, CEO, expressed optimism about future growth through the commercialization of products like Biocore Pro, Bioflux, and Biocare. The company is committed to advancing remote monitoring solutions and expanding its geographic footprint, with regulatory approvals in Canada, Saudi Arabia, Argentina, and other markets. Q: How has Biotricity managed to achieve cost efficiencies? A: The CFO explained that cost efficiencies were achieved through strategic transformation of the sales force, focusing on larger accounts and longer sales cycles. Additionally, the use of AI and automation, along with proactive cost management, contributed to positive free cash flows and a path towards profitability. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
2 days ago
- Business
- Yahoo
Biotricity Inc (BTCY) Q1 2026 Earnings Call Highlights: A Milestone Quarter with Positive ...
Release Date: August 14, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Biotricity Inc (BTCY) achieved a significant milestone by reporting positive EBITDA for the first time in its history, indicating a path towards profitability. The company reported a 21% increase in revenue for the first quarter of fiscal 2026, reaching $3.9 million, driven by strong market adoption of its technology. Biotricity Inc (BTCY) has expanded its cardiac AI cloud platform through strategic partnerships with Amazon AWS and Google's Tensorflow, enhancing diagnostic accuracy and patient outcomes. The company has secured regulatory approvals in multiple international markets, including Canada, Saudi Arabia, and Argentina, aligning with its strategy for global expansion. Gross profit for the quarter increased by 31.9% to $3.1 million, with a gross profit margin improvement to 80.5%, reflecting operational efficiencies and a strong recurring revenue base. Negative Points Despite improvements, Biotricity Inc (BTCY) reported a net loss of $754,000 for the first quarter, although this was a significant improvement from the prior year's loss. The company faces challenges with rising variable interest rates, which could impact future financial performance. Biotricity Inc (BTCY) is still in the process of pursuing FDA clearance for its AI clinical model, which could delay the full commercialization of its new technologies. Operating expenses, although reduced, remain a concern as the company continues to invest in R&D and sales force transformation. The company's expansion into new verticals and international markets may require significant resources and could face regulatory and competitive challenges. Q & A Highlights Warning! GuruFocus has detected 6 Warning Signs with BTCY. Q: Can you provide more details on the strategic partnerships mentioned in the call? A: Dr. Walkus Al Sadiq, CEO, highlighted that Biotricity has formed strategic partnerships with industry giants like Amazon AWS and Google's Tensorflow to expand their cardiac AI cloud platform. These partnerships are crucial for enhancing diagnostic accuracy and improving patient outcomes. Additionally, alliances with three major group purchasing organizations (GPOs) in the US provide access to approximately 90% of hospitals, significantly expanding market access. Q: What are the financial highlights for the first quarter of fiscal 2026? A: Johnny Abo, CFO, reported a 21% increase in revenue to $3.9 million compared to the previous year. Gross profit rose by 31.9% to $3.1 million, with a gross profit margin improvement to 80.5%. Operating expenses decreased by 18.5%, and the company achieved a positive EBITDA of $333,000, marking the first quarter of positive EBITDA in Biotricity's history. Q: How is Biotricity addressing the market for atrial fibrillation monitoring? A: The CFO emphasized that atrial fibrillation, a major contributor to strokes, remains a significant focus. Biotricity's technology has monitored over 2 trillion heartbeats, providing early intervention opportunities and improving patient outcomes. This focus not only enhances patient care but also offers potential healthcare cost savings. Q: What are the future growth prospects for Biotricity? A: Dr. Walkus Al Sadiq, CEO, expressed optimism about future growth through the commercialization of products like Biocore Pro, Bioflux, and Biocare. The company is committed to advancing remote monitoring solutions and expanding its geographic footprint, with regulatory approvals in Canada, Saudi Arabia, Argentina, and other markets. Q: How has Biotricity managed to achieve cost efficiencies? A: The CFO explained that cost efficiencies were achieved through strategic transformation of the sales force, focusing on larger accounts and longer sales cycles. Additionally, the use of AI and automation, along with proactive cost management, contributed to positive free cash flows and a path towards profitability. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19-07-2025
- Business
- Yahoo
Biotricity Inc (BTCY) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ...
Revenue (Q4 2025): $3.7 million, a 16.5% increase year-over-year. Revenue (Fiscal Year 2025): $13.8 million, up 14.3% from the prior year. Gross Profit (Q4 2025): $3 million, a 31% increase from the prior year period. Gross Margin (Q4 2025): 80.4%, an improvement of over 890 basis points from the prior year. Operating Expenses (Fiscal Year 2025): $13 million, a 24.5% decrease from the prior year. Net Loss (Fiscal Year 2025): $11.9 million, compared to $14.9 million in the prior year. Net Loss Per Share (Fiscal Year 2025): $0.555, compared to $1.66 in the prior year. Adjusted EBITDA (Q4 2025): Positive $438,000, corresponding to $0.017 per share. Adjusted EBITDA (Fiscal Year 2025): Loss of just under $1 million, improved from a loss of $7.8 million in fiscal '24. Warning! GuruFocus has detected 6 Warning Signs with BTCY. Release Date: July 18, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Biotricity Inc (BTCY) achieved a 16.5% year-over-year revenue increase in the fourth quarter, reaching $3.7 million. The company expanded its Cardiac AI cloud platform through strategic partnerships with Amazon AWS and Google's TensorFlow, enhancing diagnostic accuracy and patient outcomes. Biotricity Inc (BTCY) secured strategic alliances with three major group purchasing organizations, providing access to approximately 90% of U.S. hospitals. The company achieved positive adjusted EBITDA of $438,000 in the last quarter of fiscal 2025, indicating progress towards profitability. Biotricity Inc (BTCY) received regulatory approval in Saudi Arabia, aligning with its strategy to expand internationally and improve patient outcomes. Negative Points Biotricity Inc (BTCY) reported a net loss attributable to common stockholders of $11.9 million for the fiscal year ended March 31, 2025. The sales cycles for new partnerships and pilots with GPOs are lengthy, potentially delaying revenue realization. Despite improvements, the company still faces challenges in achieving profitability, with a net loss per share of $0.555 for the fiscal year. The company lacks in-house expertise to monetize its extensive data set, which could be a missed opportunity for additional revenue. Biotricity Inc (BTCY) anticipates that international market revenue contributions, such as from Saudi Arabia, may not significantly impact financials until 2026. Q & A Highlights Q: When can we expect greater acceleration in terms of revenue from your GPO relationships? A: Waqaas Al-Siddiq, CEO: The GPOs involve long sales cycles, often taking up to a year. We are currently engaging in pilots with large, multistate organizations. Revenue will start to trickle in as these pilots conclude and roll out over the next few quarters. Q: Which cost levers give you confidence that margins can stay above 80% in 2026? A: Waqaas Al-Siddiq, CEO: Our technology, particularly data analysis and device output, provides high margins. We've achieved economies of scale, reducing costs for each new device added to our platform, which helps maintain high margins. Q: Can the data set of over 1 trillion heartbeats be monetized beyond improving clinical algorithms? A: Waqaas Al-Siddiq, CEO: Yes, there is potential to monetize this data, especially given the focus on cardiac health. While we currently lack the in-house skill set to package and sell this data, we plan to invest in this area as we reach profitability. Q: What are your efforts in pursuing FDA clearance for your AI clinical model? A: Waqaas Al-Siddiq, CEO: We are in the process of analyzing data and bringing in experts for secondary input. We plan to present this to the FDA in a pre-submission meeting to ensure our approach aligns with their requirements. This is a complex process, but we are targeting significant opportunities. Q: How do you see the Saudi Arabian market impacting revenue for the rest of 2025 and next year? A: Waqaas Al-Siddiq, CEO: We expect significant impact in 2026. We aim for 20-30% of our business to be international in the coming years. For next year, we anticipate $0.5 million to $1 million in added revenue from international distribution partnerships. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error al recuperar los datos Inicia sesión para acceder a tu cartera de valores Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos
Forbes
29-06-2025
- Forbes
Potential Cyber Threat Emerges As MOVEit Scanning Accelerates
Scanning activity targeting MOVEit Transfer systems surges globally, raising fears of another ... More widespread exploitation campaign. Progress Software's MOVEit Transfer system is back in the cybersecurity spotlight — and not for good reasons. New telemetry from GreyNoise shows a sharp and sudden surge in scanning activity, raising fears that attackers may be preparing for a fresh wave of exploitation, echoing the mass compromise campaigns of 2023. A Sudden Shift That Demands Attention On May 27, GreyNoise recorded a striking jump in the number of unique IPs probing MOVEit Transfer systems. Scanning activity, previously hovering below 10 IPs per day, skyrocketed to over 100. The next day, it surged to 319. Since then, daily scans have remained high, fluctuating between 200 and 300 unique IPs — a pattern that GreyNoise calls a 'significant deviation' from baseline behavior. These aren't just idle scans. Nearly half of the probing IPs — 44% — are associated with Tencent Cloud. Others originate from Amazon AWS, Cloudflare, and Google Cloud, platforms often abused for mass-scale reconnaissance due to their ease of access and global reach. The scans are originating primarily from the United States, but also span Germany, Japan, Singapore, Brazil, and other countries. The targets are globally distributed, with GreyNoise noting attempted access across the UK, Germany, France, and Mexico. Echoes of 2023 MOVEit Transfer made headlines just a couple years ago when a critical SQL injection vulnerability (CVE-2023-34362) was exploited by the Cl0p ransomware group. That zero-day led to breaches at hundreds of organizations, including government agencies and major corporations. The attackers used automated scanning and mass exploitation to infiltrate unpatched instances at scale. The current surge raises concerns that we may be witnessing a similar prelude. Attackers are known to conduct broad reconnaissance to identify unpatched or misconfigured systems before launching widespread attacks. GreyNoise's detection of sustained scanning over multiple weeks — rather than a short spike — suggests that reconnaissance is ongoing, possibly automated, and potentially linked to active threat actors preparing an operation. But not all experts see this as a clear sign of an imminent threat. 'The increase in scanning activity targeting MOVEit Transfer systems is worth monitoring, but doesn't necessarily indicate imminent or widespread exploitation,' said Shane Barney, CISO at Keeper Security. 'This type of behavior often reflects opportunistic threat actors probing for unpatched systems – not necessarily a sophisticated adversary.' Still, Barney acknowledged the high stakes: 'The MOVEit vulnerabilities have a history of being exploited at scale, with significant consequences, so organizations must remain vigilant.' What to Do Now Security leaders should act now, not later. Here's what should be prioritized: Nivedita Murthy, senior staff consultant at Black Duck, emphasized that attackers are quick to capitalize on lapses in patching. 'Attackers are exploiting a vulnerability in outdated versions of MOVEit Transfer, emphasizing the importance of keeping software up-to-date with the latest patches,' she said. Murthy also noted the growing role of automation in these campaigns: 'With the help of AI, attackers can automate a lot of their tasks and run attacks faster while making them harder to detect.' She recommends a layered defense, starting with visibility: 'Security teams should inventory all instances of the software using SCA tools, implement additional controls such as authentication and authorization, and regularly scan their software inventory for risks.' Maintaining accurate Software Bills of Materials, she added, is also critical to managing risk and 'helps confidently unleash business innovation in an era of accelerating risk.' Cloud Platforms as Recon-as-a-Service There's also a broader trend at play: cloud infrastructure is now a top tool for adversaries. Spinning up virtual machines on public cloud services takes minutes and costs pennies. That makes them perfect for running scanning scripts or launching low-and-slow enumeration attacks while obscuring true attribution. Tencent Cloud's appearance in this story is notable, not because the company is complicit, but because of the volume. With nearly half of scanner IPs traced back to Tencent's ASN, it's clear adversaries see value in its global footprint and accessibility. This development calls for better coordination between cloud providers and the security community to detect, report, and tear down abuse infrastructure before it's weaponized. A Warning, Not Yet a Breach While the scanning activity may not yet point to a coordinated exploit campaign, the patterns are uncomfortably familiar. Last year's MOVEit breaches didn't start with explosions — they started with quiet reconnaissance. 'Ensuring patches are applied, systems aren't unnecessarily exposed, and privileged access is tightly controlled are all foundational steps that help reduce risk,' Barney advised. 'While cybercrime groups may attempt to speed up and scale campaigns with automation or AI, core defense strategies remain the same: establish a zero-trust architecture, manage privileged access, and use real-time threat detection.' This isn't cause for panic…yet. But it is a call to be prepared. Threat actors are scanning. Whether or not they act depends, in part, on whether defenders leave the door open.
